Curcumin inhibits high glucose‑induced inflammatory injury in human retinal pigment epithelial cells through the ROS‑PI3K/AKT/mTOR signaling pathway

Ran,Zhenlong; Zhang,Yueling; Wen,Xiaoying; Ma,Jingxue

doi:10.3892/mmr.2018.9749

Curcumin inhibits high glucose‑induced inflammatory injury in human retinal pigment epithelial cells through the ROS‑PI3K/AKT/mTOR signaling pathway

Authors:
- Zhenlong Ran
- Yueling Zhang
- Xiaoying Wen
- Jingxue Ma
View Affiliations

Affiliations: Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, The Second Department of Ophthalmology, Baoding First Central Hospital of Hebei Province, Baoding, Hebei 071000, P.R. China
Published online on: December 12, 2018 https://doi.org/10.3892/mmr.2018.9749
Pages: 1024-1031
Copyright: © Ran et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic retinopathy (DR) is a retinal disease caused by metabolic disorders of glucose tolerance that can lead to irreversible blindness if not adequately treated. Retinal pigment epithelial cell (RPEC) dysfunction contributes to the pathogenesis of DR. In the present study the anti‑inflammatory effect of curcumin (CUR) was investigated in RPECs damaged by high glucose levels. RPEC treated with 30 mmol/l glucose was regarded as high glucose group, and cells treated with 24.4 mmol/l mannitol was set as equivalent osmolarity group. Cell Counting Kit‑8 assay was used to measure RPEC viability, the expression of phosphorylated (p)‑AKT and p‑mammalian target of rapamycin (mTOR) were assessed by western blot, and secretion of tumor necrosis factor (TNF)‑α, interleukin (IL)‑6 and IL‑1β in the culture medium was measured by ELISA. Intracellular reactive oxygen species (ROS) levels were measured by laser scanning confocal microscope. The present data indicated that, compared with mannitol treatment, high glucose treatment reduced RPEC viability, increased TNF‑α, IL‑6 and IL‑1β secretion, increased ROS formation and promoted phosphorylation of AKT and mTOR. The antioxidant N‑acetylcysteine, the phosphoinositide 3‑kinase (PI3K)/AKT inhibitor LY294002 and the mTOR inhibitor rapamycin ameliorated the effects of high glucose. In addition, pretreatment with 10 µmol/l CUR reduced secretion levels of TNF‑α, IL‑6 and IL‑1β, ROS formation and phosphorylation of AKT and mTOR. In conclusion, CUR inhibited high glucose‑induced inflammatory injury in RPECs by interfering with the ROS/PI3K/AKT/mTOR signaling pathway. The present study may reveal the molecular mechanism of CUR inhibition effects to high glucose‑induced inflammatory injury in RPEC.

View Figures

View References

1	Chang LY, Lee AC and Sue W: Prevalence of diabetic retinopathy at first presentation to the retinal screening service in the greater Wellington region of New Zealand 2006–2015, and implications for models of retinal screening. N Z Med J. 130:78–88. 2017.PubMed/NCBI
2	Maugh TH II: Diabetic retinopathy: New ways to prevent blindness. Science. 192:539–540. 1976. View Article : Google Scholar : PubMed/NCBI
3	Ahmed MS and Tahrani A: Diabetic retinopathy in cystic fibrosis related diabetes. Diabetologia. 60:S472–S473. 2017.
4	Byberg S, Jorgensen ME, Larsen M, Lundandersen H and Vistisen D: Risk score for diabetic retinopathy. Diabetes. 66:A1612017.
5	Bajestani NS, Kamyad AV, Esfahani EN and Zare A: Prediction of retinopathy in diabetic patients using type-2 fuzzy regression model. Eur J Oper Res. 264:859–869. 2018. View Article : Google Scholar
6	Zvornicanin J and Zvorničanin E: Imaging in diabetic retinopathy. Middle East Afr J Ophthalmol. 22:5312015. View Article : Google Scholar : PubMed/NCBI
7	Pasquel FJ, Hendrick AM, Ryan M, Cason E, Ali MK and Narayan KM: Cost-effectiveness of different diabetic retinopathy screening modalities. J Diabetes Sci Technol. 10:301–307. 2015. View Article : Google Scholar : PubMed/NCBI
8	Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN and Januszewski AS: Biomarkers in diabetic retinopathy. Rev Diabet Stud. 12:159–195. 2015. View Article : Google Scholar : PubMed/NCBI
9	Hurley B: Therapeutic revolution in the management of diabetic retinopathy. Can J Ophthalmol. 52 Suppl 1:S1–S2. 2017. View Article : Google Scholar : PubMed/NCBI
10	Vaziri K, Schwartz SG, Relhan N, Kishor KS and Flynn HW Jr: New therapeutic approaches in diabetic retinopathy. Rev Diabet Stud. 12:196–210. 2015. View Article : Google Scholar : PubMed/NCBI
11	Tang J and Kern TS: Inflammation in diabetic retinopathy. Prog Retin Eye Res. 30:343–358. 2011. View Article : Google Scholar : PubMed/NCBI
12	Rangasamy S, McGuire PG and Das A: Diabetic retinopathy and inflammation: Novel therapeutic targets. Middle East Afr J Ophthalmol. 19:52–59. 2012. View Article : Google Scholar : PubMed/NCBI
13	Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, et al: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18:1450–1452. 2004. View Article : Google Scholar : PubMed/NCBI
14	Abcouwer SF and Antonetti DA: A role for systemic inflammation in diabetic retinopathy. Invest Ophthalmol Vis Sci. 54:23842013. View Article : Google Scholar : PubMed/NCBI
15	Behl T, Kaur I and Kotwani A: Implication of oxidative stress in progression of diabetic retinopathy. Surv Ophthalmol. 61:187–196. 2016. View Article : Google Scholar : PubMed/NCBI
16	Kowluru RA and Mishra M: Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim Biophys Acta. 1852:2474–2483. 2015. View Article : Google Scholar : PubMed/NCBI
17	Kowluru RA, Kowluru A, Mishra M and Kumar B: Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 48:40–61. 2015. View Article : Google Scholar : PubMed/NCBI
18	Calderon GD, Juarez OH, Hernandez GE, Punzo SM and De la Cruz ZD: Oxidative stress and diabetic retinopathy: Development and treatment. Eye (Lond). 31:1122–1130. 2017. View Article : Google Scholar : PubMed/NCBI
19	Choudhury AK, Raja S, Mahapatra S, Nagabhushanam K and Majeed M: Synthesis and evaluation of the anti-oxidant capacity of curcumin glucuronides, the major curcumin metabolites. Antioxidants (Basel). 4:750–767. 2015. View Article : Google Scholar : PubMed/NCBI
20	Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV and Anderson RE: Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med. 46:672–679. 2009. View Article : Google Scholar : PubMed/NCBI
21	Xie M, Fan D, Zhao Z, Li Z, Li G, Chen Y, He X, Chen A, Li J, Lin X, et al: Nano-curcumin prepared via supercritical: Improved anti-bacterial, anti-oxidant and anti-cancer efficacy. Int J Pharm. 496:732–740. 2015. View Article : Google Scholar : PubMed/NCBI
22	Baghdasaryan A, Claudel T, Kosters A, Gumhold J, Silbert D, Thüringer A, Leski K, Fickert P, Karpen SJ and Trauner M: Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut. 59:521–530. 2010. View Article : Google Scholar : PubMed/NCBI
23	Bisht S, Khan MA, Bekhit M, Bai H, Cornish T, Mizuma M, Rudek MA, Zhao M, Maitra A, Ray B, et al: A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest. 91:1383–1395. 2011. View Article : Google Scholar : PubMed/NCBI
24	Fu Y, Gao R, Cao Y, Guo M, Wei Z, Zhou E, Li Y, Yao M, Yang Z and Zhang N: Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-κB signaling pathway in lipopolysaccharide-induced mastitis in mice. Int Immunopharmacol. 20:54–58. 2014. View Article : Google Scholar : PubMed/NCBI
25	Das L and Vinayak M: Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice. Biosci Rep. 32:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
26	Heng MC: Curcumin targeted signaling pathways: Basis for anti-photoaging and anti-carcinogenic therapy. Int J Dermatol. 49:608–622. 2010. View Article : Google Scholar : PubMed/NCBI
27	Samuels TL, Pearson AC, Wells CW, Stoner GD and Johnston N: Curcumin and anthocyanin inhibit pepsin-mediated cell damage and carcinogenic changes in airway epithelial cells. Ann Otol Rhinol Laryngol. 122:632–641. 2013.PubMed/NCBI
28	Aldebasi YH, Aly SM and Rahmani AH: Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Int J Physiol Pathophysiol Pharmacol. 5:194–202. 2013.PubMed/NCBI
29	Steigerwalt R, Nebbioso M, Appendino G, Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, et al: Meriva^®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med. 54:11–16. 2012.PubMed/NCBI
30	Su Q, Wang Y, Yang X, Li XD, Qi YF, He XJ and Wang YJ: Inhibition of endoplasmic reticulum stress apoptosis by estrogen protects human umbilical vein endothelial cells through the PI3 Kinase-Akt signaling pathway. J Cell Biochem. 118:4568–4574. 2017. View Article : Google Scholar : PubMed/NCBI
31	Mao N, Cheng Y, Shi XL, Wang L, Wen J, Zhang Q, Hu QD and Fan JM: Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro. Acta Pharmacol Sin. 35:513–522. 2014. View Article : Google Scholar : PubMed/NCBI
32	Ahsan H: Diabetic retinopathy-biomolecules and multiple pathophysiology. Diabetes Metab Syndr. 9:51–54. 2015. View Article : Google Scholar : PubMed/NCBI
33	White C, DiStefano T and Olabisi R: The influence of substrate modulus on retinal pigment epithelial cells. J Biomed Mater Res A. 105:1260–1266. 2017. View Article : Google Scholar : PubMed/NCBI
34	Okamura N, Ito Y, Shibata MA, Ikeda T and Otsuki Y: Fas-mediated apoptosis in human lens epithelial cells of cataracts associated with diabetic retinopathy. Med Electron Microsc. 35:234–241. 2002. View Article : Google Scholar : PubMed/NCBI
35	Zhou W, Yu W, Xie W, Huang L, Xu Y and Li X: The role of SLIT-ROBO signaling in proliferative diabetic retinopathy and retinal pigment epithelial cells. Mol Vis. 17:1526–1536. 2011.PubMed/NCBI
36	Kim DI, Park MJ, Lim SK, Choi JH, Kim JC, Han HJ, Kundu TK, Park JI, Yoon KC, Park SW, et al: High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: Role in diabetic retinopathy. Arch Biochem Biophys. 560:36–43. 2014. View Article : Google Scholar : PubMed/NCBI
37	Song MK, Roufogalis BD and Huang TH: Reversal of the caspase-dependent apoptotic cytotoxicity pathway by taurine from Lycium barbarum (Goji Berry) in human retinal pigment epithelial cells: Potential benefit in diabetic retinopathy. Evid Based Complement Alternat Med. 2012:3237842012. View Article : Google Scholar : PubMed/NCBI
38	Kaštelan S, Tomić M, Gverović Antunica A, Salopek Rabatić J and Ljubić S: Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm. 2013:2131302013. View Article : Google Scholar : PubMed/NCBI
39	El-Asrar AM: Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol. 19:70–74. 2012. View Article : Google Scholar : PubMed/NCBI
40	Sun J, Huang P, Liang J, Li J, Shen M, She X, Feng Y, Luo X, Liu T and Sun X: Cooperation of Rel family members in regulating Aβ_1-40-mediated pro-inflammatory cytokine secretion by retinal pigment epithelial cells. Cell Death Dis. 8:e31152017. View Article : Google Scholar : PubMed/NCBI
41	Singh M and Tyagi SC: Homocysteine mediates transcriptional changes of the inflammatory pathway signature genes in human retinal pigment epithelial cells. Int J Ophthalmol. 10:696–704. 2017.PubMed/NCBI
42	Kutty RK, Samuel W, Duncan T, Postnikova O, Jaworski C, Nagineni CN and Redmond TM: Proinflammatory cytokine interferon-γ increases the expression of BANCR a long non-coding RNA, in retinal pigment epithelial cells. Cytokine. 104:147–150. 2018. View Article : Google Scholar : PubMed/NCBI
43	Shah MS and Brownlee M: Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 118:1808–1829. 2016. View Article : Google Scholar : PubMed/NCBI
44	Wu T, Peng Y, Yan S, Li N, Chen Y and Lan T: Andrographolide ameliorates atherosclerosis by suppressing pro-inflammation and ROS generation-mediated foam cell formation. Inflammation. 41:1681–1689. 2018. View Article : Google Scholar : PubMed/NCBI
45	Wang Y and Tabas I: Emerging roles of mitochondria ROS in atherosclerotic lesions: Causation or association? J Atheroscler Thromb. 21:381–390. 2014. View Article : Google Scholar : PubMed/NCBI
46	Kanellakis P, Pomilio G, Walker C, Husband A, Huang JL, Nestel P, Agrotis A and Bobik A: A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling. Atherosclerosis. 204:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
47	Chen W, Zhao M, Zhao S, Lu Q, Ni L, Zou C, Lu L, Xu X, Guan H, Zheng Z and Qiu Q: Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: A novel inhibitory effect of minocycline. Inflamm Res. 66:157–166. 2017. View Article : Google Scholar : PubMed/NCBI
48	Wu X, Long L, Liu J, Zhang J, Wu T, Chen X, Zhou B and Lv TZ: Gambogic acid suppresses inflammation in rheumatoid arthritis rats via PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 16:7112–7118. 2017. View Article : Google Scholar : PubMed/NCBI
49	Choi YH, Jin GY, Li LC and Yan GH: Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway. PLoS One. 8:e817732013. View Article : Google Scholar : PubMed/NCBI
50	Weber WM, Hunsaker LA, Abcouwer SF, Deck LM and Vander Jagt DL: Anti-oxidant activities of curcumin and related enones. Bioorg Med Chem. 13:3811–3820. 2005. View Article : Google Scholar : PubMed/NCBI
51	Edwards RL, Luis PB, Varuzza PV, Joseph AI, Presley SH, Chaturvedi R and Schneider C: The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites. J Biol Chem. 292:21243–21252. 2017. View Article : Google Scholar : PubMed/NCBI
52	Fazal Y, Fatima SN, Shahid SM and Mahboob T: Effects of curcumin on angiotensin-converting enzyme gene expression, oxidative stress and anti-oxidant status in thioacetamide-induced hepatotoxicity. J Renin Angiotensin Aldosterone Syst. 16:1046–1051. 2015. View Article : Google Scholar : PubMed/NCBI
53	Tian B, Zhao Y, Liang T, Ye X, Li Z, Yan D, Fu Q and Li Y: Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway. J Drug Target. 25:626–636. 2017. View Article : Google Scholar : PubMed/NCBI
54	Cianciulli A, Calvello R, Porro C, Trotta T, Salvatore R and Panaro MA: PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia. Int Immunopharmacol. 36:282–290. 2016. View Article : Google Scholar : PubMed/NCBI